Hamilton Beach Q1 Earnings Rise Y/Y, Tariffs Cloud 2025 Outlook

02.05.25 18:34 Uhr

Werte in diesem Artikel
Aktien

33,00 JPY 1,00 JPY 3,13%

Shares of Hamilton Beach Brands Holding Company HBB have declined 23.2% since reporting results for the first quarter of 2025. This compares with the S&P 500 index’s 0.63% growth over the same time frame. Over the past month, the stock has declined 16.3% against the S&P 500’s 3.4% rally.Earnings Rebound on Higher Margins & Improved VolumeIn the first quarter ended March 31, 2025, Hamilton Beach reported revenues of $133.4 million, up 4% from $128.3 million in the same period last year. Gross profit rose 9% to $32.8 million, with the gross margin expanding 120 basis points to 24.6% from 23.4% a year earlier. Net income stood at $1.8 million, or 13 cents per diluted share, against a net loss of $1.2 million, or 8 cents per diluted share, a year ago.Hamilton Beach Brands Holding Company Price, Consensus and EPS Surprise  Hamilton Beach Brands Holding Company price-consensus-eps-surprise-chart | Hamilton Beach Brands Holding Company QuoteOperating Highlights & Key Business MetricsOperating profit reached $2.3 million, marking a $3.2-million improvement over the prior year’s $0.9-million operating loss. SG&A expenses declined slightly to $30.4 million due to the absence of prior-year transaction costs related to the HealthBeacon acquisition.Cash flow from operations was $6.6 million, down from $19.7 million a year ago. The decline stemmed from higher inventory levels due to tariff-related pull-forward activity and a tough comparison to prior-year improvements in receivables collections.Strength in Core Segments & Strategic ExpansionHamilton Beach’s first-quarter gains were driven by its North America consumer business, particularly in the United States, supported by positive at-home dining trends. The Premium and Health segments also contributed to gross margin expansion. HealthBeacon, acquired in early 2024, generated $1.5 million in revenues and operated at higher margins, boosting consolidated profitability. Notably, HealthBeacon achieved its third consecutive quarter of rising patient subscriptions, positioning the segment for above 50% growth in 2025, supported by an upcoming partnership with OptumHealth.Premium segment brands like Numilk and CHI saw strong consumer demand, especially through product launches and partnerships with major retailers. The company plans to strengthen its premium offering with the launch of Lotus, a new brand targeting high-end home cooks, with seven products slated for release later in the year.E-commerce accounted for roughly 40% of U.S. consumer sales and grew in the mid-single digits, supported by performance across digital platforms and retail partner sites. International revenues were slightly down due to weakness in select global markets.Executive Perspective: Managing Through Trade UncertaintyCEO Scott Tidey acknowledged solid momentum from the 2024 holiday season carrying into early 2025. However, visibility dimmed following the imposition of retaliatory tariffs in April, which increased levies on China imports to 145%. Management has taken several steps to mitigate the impacts, including implementing price increases, accelerating sourcing diversification and certifying its primary distribution center as a foreign trade zone.Tidey emphasized that around 15% of the United States-bound manufacturing has already shifted away from China, with expectations for two-thirds to be sourced elsewhere by the end of 2025. These changes are projected to positively impact margins in 2026.Cautious Outlook Amid Global Trade VolatilityWhile first-quarter results initially positioned HBB on track to meet full-year targets, escalating tariff uncertainty has prompted the company to suspend forward guidance. CFO Sally Cunningham cited the unpredictability of global trade negotiations as the basis for this decision. Nonetheless, management reaffirmed its confidence in existing mitigation strategies, including targeted price hikes and pre-buying inventory before tariffs took effect.Other DevelopmentsHamilton Beach repurchased 141,435 shares in the quarter for $2.7 million and paid out $1.6 million in dividends, underscoring a continued commitment to shareholder returns. As of March 31, 2025, the company’s net debt stood at $1.7 million, down sharply from $23.7 million a year earlier. Capital expenditure totaled $516,000, and the company ended the quarter with $48.3 million in cash.The Health segment, which includes the HealthBeacon platform, continued its growth trajectory with a third consecutive quarter of rising patient subscriptions. A new partnership with OptumHealth is expected to contribute to growth beginning in the second quarter.Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Hamilton Beach Brands Holding Company (HBB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf RISE

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf RISE

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu RISE Inc.

Wer­bung